跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
CIMA-AEMPS
/
ATORVASTATINA DAVURGAMA 30 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA
Approved
STANDARD
ATORVASTATINA DAVURGAMA 30 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA
Teva Pharma S.L.U.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Nov 12, 2024
Approval ID
90a502d564eef1ef
Company
Teva Pharma S.L.U.
Type
Standard
Approval Details
Approval Id
90a502d564eef1ef
Drug Cima Aemps Name
ATORVASTATINA DAVURGAMA 30 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA
Register Number
89942
Holder Company Name
Teva Pharma S.L.U.
Marketing Company Name
Teva Pharma S.L.U.
Authorization Date
2024-11-12
Dosage Form
COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose
30 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
Yes
Company Name
Teva Pharma S.L.U.
Active Ingredients
ATORVASTATINA CALCICA
31,08 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Nov 12, 2024
Approval ID
90a502d564eef1ef
Type
Standard
Back to CIMA-AEMPS Approvals